About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Anthem Biosciences Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
544449
ISIN Demat
INE0CZ201020
Book Value
52.80
NSE Code
ANTHEM
Dividend Yield %
0.00
Market Cap
394800.58
P/E
77.99
EPS
9.01
Face Value
2
BSE
NSE
26-Feb-2026
BSE
NSE
NSE F & O
26-Feb-2026
BSE
NSE
NSE F & O
Last Price
702.85
Net Change
-0.75
% Change
-0.11%
Prev.Close
703.60
Open
711.00
High
711.00
Low
693.10
Volume
4600
Last Price
703.50
Net Change
-0.6
% Change
-0.09%
Prev.Close
704.10
Open
713.00
High
713.95
Low
693.00
Volume
89829
Value
3221911
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
711.00
52-Week High
873.25
52-Week Low
579.45
Value
63050653.65
Best Buy
0.00
Best Sell
703.50
Best Quantity
0
Sell Quantity
1410
Today's Range
713.95
52-Week High
873.50
52-Week Low
579.15
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
1410
Price
703.50
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Company News
07-01-2026
Anthem Biosciences inform...
15-12-2025
Anthem Biosciences inform...
29-09-2025
Anthem Biosciences inform...
14-08-2025
Anthem Biosciences report...
14-08-2025
Anthem Biosciences trades...
21-07-2025
Anthem Biosciences lists ...
11-07-2025
Anthem Biosciences coming...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.